Raymond Mailhot: Advancing Hodgkin Lymphoma Survivor Study with NCI Funding
Raymond Mailhot, Associate Professor of Radiation Oncology at the University of Florida College of Medicine, shared a post on LinkedIn:
“Pizza party with our amazing research team.
We’re almost at the halfway point of planned study enrollment in the few months since receiving the NOA of our National Cancer Institute (NCI) funded R37, focusing on improving outcomes for survivors of Hodgkin lymphoma. Tomorrow, Erin Mobley and I head to DC for CancerCon (hosted by Stupid Cancer).
We’ll also be stopping by the congressional offices of our representatives to share about the importance of NIH funding, including the news that our study has had interest from 345 survivors across 44 states in the US!
This success is in part to the strength of our research team: Robin Cacchio, Ed Michel, Jackie Causer, Audrey Gardner.”
More posts featuring Raymond Mailhot on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023